In addition, several investigational therapies are described. Childhood obesity, pharmacological and hormonal basis for treatment. The authors present two interesting cases of infants with cystic fibrosis who were treated with ursodeoxycholic acid within the first 6 weeks of life. In these two infants, the diagnosis of CF was made after presentation with meconium ileus. Ursodeoxycholic acid was added for subsequent symptoms of hepatobiliary disease.
Ursodeoxycholic acid improves cholestasis in infants with cystic fibrosis.
While the methodology section of this paper will likely be enjoyed only by true pharmacokinetic enthusiasts, the results are well worth reading by all clinicians treating babies. The authors conclude that the standard technique of obtaining only two vancomycin samples is adequate for two-compartment modeling, when one is obtained 30 minutes following a dose and another immediately prior to a dose. This lotion may be applied 1-3 times daily. The quarterly summation of the Adverse Drug Reaction Reporting Program was presented. There is a new resource available for health care providers who counsel the parents of young children on medications.